Impact of Cytochrome P450 2C19*2 Polymorphism on Intra-Stent Thrombus After drug eluting stent Implantation Receiving Clopidogrel.
Not Applicable
- Conditions
- Stable coronary artery disease
- Registration Number
- JPRN-UMIN000008058
- Lead Sponsor
- Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)The patient who has a plan to receive surgical procedure. 2)The patient who received anticoagulant agent, thrombolytic drug, antiplatelet drug other than aspirin or clopidogrel. 3)There is contraindication of aspirin or clopidogrel. 4)The patient who do not agree with this trial. 5)inappropriate patient.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method